Electrophysiologic properties of a new antiarrhythmic drug--tocainide.
D000200:Action Potentials / Q000187:drug effects; D000813:Anilides / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control; D002304:Cardiac Pacing, Artificial; D004285:Dogs; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects*; D008012:Lidocaine / Q000494:pharmacology; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects*; D010042:Ouabain; D011690:Purkinje Fibers / Q000187:drug effects; D013610:Tachycardia / Q000517:prevention & control; D014693:Ventricular Fibrillation / Q000517:prevention & control
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D010042:Ouabain; D008012:Lidocaine